Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-11-002429
Filing Date
2011-11-07
Accepted
2011-11-07 17:27:35
Documents
13
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT therap_10q-093011.htm 10-Q 1106350
2 LICENSE AGREEMENT ex-10_13.htm EX-10.13 78267
3 302 CERTIFICATION OF THE CEO ex-31_1.htm EX-31.1 15475
4 302 CERTIFICATION OF THE CFO ex-31_2.htm EX-31.2 15483
5 906 CERTIFICATION OF THE CEO ex-32_1.htm EX-32.1 6135
6 906 CERTIFICATION OF THE CFO ex-32_2.htm EX-32.2 5882
13 vitamedmd.jpg GRAPHIC 10544
  Complete submission text file 0001387131-11-002429.txt   2863550

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT amhnob-20110930.xml EX-101.INS 351494
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amhnob-20110930.xsd EX-101.SCH 10730
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amhnob-20110930_cal.xml EX-101.CAL 22542
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amhnob-20110930_def.xml EX-101.DEF 6318
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amhnob-20110930_lab.xml EX-101.LAB 94145
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amhnob-20110930_pre.xml EX-101.PRE 61771
Mailing Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487
Business Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487 516-961-1911
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16731 | Film No.: 111185618
SIC: 2834 Pharmaceutical Preparations